Publications
89
Citations
1,177
Est. group size
—
Recurring co-author estimate
Active years
56
Publishing since 1970
Typically publishes in teams of ~9 · 18% small-team papers (≤3 authors) · across 31 venues
- Safety and Efficacy of Tumor-Infiltrating Lymphocyte Therapy with Reduced-Dose Lymphodepleting Conditioning in High-Risk Metastatic Melanoma Patients
Transplantation and Cellular Therapy · 2025
- The Use of Radar-Guided Localization to Identify Metastatic Melanoma After Neoadjuvant Immunotherapy
Annals of Surgical Oncology · 2025
- Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative, or Not Performed Sentinel Lymph Node Biopsy
Annals of Surgical Oncology · 2025
- Management of In-Transit Metastatic Melanoma
Hematology/Oncology Clinics of North America · 2025
- Multimodal Classroom Diarization with GPT Re-scoring: Teacher or Student?
Lecture notes in computer science · 2025
- Infusion product characteristics to predict response to tumor-infiltrating lymphocyte (TIL) therapy in metastatic melanoma (MM).
Journal of Clinical Oncology · 2025
- ASO Visual Abstract: The Use of Radar-Guided Localization to Identify Metastatic Melanoma After Neoadjuvant Immunotherapy
Annals of Surgical Oncology · 2025
- Clinical and biomarker analyses of first-line nivolumab and relatlimab (nivo-rela) in advanced or resectable melanoma (mel).
Journal of Clinical Oncology · 2025
- A phase II study of neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma.
Journal of Clinical Oncology · 2025
- 63965 Scrotal melanoma: A single institution review for a rare subtype of melanoma
Journal of the American Academy of Dermatology · 2025
- 1346 Molecular and immunologic correlates of response in a phase II study of neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma
2025
- ASO Visual Abstract: Recurrence and Survival Outcomes in Patients with Primary Merkel Cell Carcinoma with Positive, Negative or Not Performed Sentinel Lymph Node Biopsy
Annals of Surgical Oncology · 2025
- The efficacy and safety of mirvetuximab soravtansine in FRα-positive, third-line and later, recurrent platinum-sensitive ovarian cancer: the single-arm phase II PICCOLO trial
Annals of Oncology · 2024
- Management of acral lentiginous melanoma: current updates and future directions
Frontiers in Oncology · 2024
- Intralesional and Infusional Updates for Metastatic Melanoma
Cancers · 2024
- Annals of Surgical Oncology×11
- Journal of Clinical Oncology×4
- Journal of the American College of Surgeons×3
- arXiv (Cornell University)×3
- Annals of Oncology×2
- R.L. Belote
Medicine · The Ohio State University
- Aleodor A. Andea
Medicine · University of Michigan
- Carlo M. Contreras
Medicine · The Ohio State University
- Lori Lowe
Medicine · University of Michigan
- Emily Kim
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile